These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 9698084

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In vitro biotransformation of the selective serotonin reuptake inhibitor citalopram, its enantiomers and demethylated metabolites by monoamine oxidase in rat and human brain preparations.
    Kosel M, Gnerre C, Voirol P, Amey M, Rochat B, Bouras C, Testa B, Baumann P.
    Mol Psychiatry; 2002; 7(2):181-8. PubMed ID: 11840311
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Stereoselective single-dose kinetics of citalopram and its metabolites in rats.
    Kugelberg FC, Carlsson B, Ahlner J, Bengtsson F.
    Chirality; 2003 Aug; 15(7):622-9. PubMed ID: 12840828
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic consequences of a citalopram treatment discontinuation.
    Voirol P, Rubin C, Bryois C, Kosel M, Buclin T, Baumann P.
    Ther Drug Monit; 1999 Jun; 21(3):263-6. PubMed ID: 10365634
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dynamic and kinetic effects of chronic citalopram treatment in experimental hepatic encephalopathy.
    Apelqvist G, Wikell C, Carlsson B, Hjorth S, Bergqvist PB, Ahlner J, Bengtsson F.
    Clin Neuropharmacol; 2000 Jun; 23(6):304-17. PubMed ID: 11575864
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.
    Baumann P.
    Clin Pharmacokinet; 1996 Dec; 31(6):444-69. PubMed ID: 8968657
    [Abstract] [Full Text] [Related]

  • 13. Stereoselective metabolism of citalopram in plasma and cerebrospinal fluid of depressive patients: relationship with 5-HIAA in CSF and clinical response.
    Nikisch G, Mathé AA, Czernik A, Eap CB, Jiménez-Vasquez P, Brawand-Amey M, Baumann P.
    J Clin Psychopharmacol; 2004 Jun; 24(3):283-90. PubMed ID: 15118482
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Therapeutic drug monitoring of racemic citalopram: a 5-year experience in Sweden, 1992-1997.
    Reis M, Lundmark J, Bengtsson F.
    Ther Drug Monit; 2003 Apr; 25(2):183-91. PubMed ID: 12657912
    [Abstract] [Full Text] [Related]

  • 17. In vivo steady-state pharmacokinetic outcome following clinical and toxic doses of racemic citalopram to rats.
    Kugelberg FC, Apelqvist G, Carlsson B, Ahlner J, Bengtsson F.
    Br J Pharmacol; 2001 Apr; 132(8):1683-90. PubMed ID: 11309239
    [Abstract] [Full Text] [Related]

  • 18. Citalopram in vitro metabolism in a Beagle dog: A role for CYP2D15 in the production of toxic didesmethylcitalopram?
    Rochat B, Paus E, Maitre C, Baumann P.
    Vet Med (Praha); 2023 Apr; 68(4):135-144. PubMed ID: 37982088
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Analysis of enantiomers of citalopram and its demethylated metabolites in plasma of depressive patients using chiral reverse-phase liquid chromatography.
    Rochat B, Amey M, Baumann P.
    Ther Drug Monit; 1995 Jun; 17(3):273-9. PubMed ID: 7624924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.